Meristem Family Wealth, LLC Mei Pharma, Inc. Call Options Transaction History
Meristem Family Wealth, LLC
- $0
- Q3 2022
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding MEIP
# of Institutions
1Shares Held
2KCall Options Held
0Put Options Held
0About MEI Pharma, Inc.
- Ticker MEIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 133,261,000
- Market Cap $414M
- Description
- MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...